切换至 "中华医学电子期刊资源库"

中华肥胖与代谢病电子杂志 ›› 2019, Vol. 05 ›› Issue (03) : 157 -160. doi: 10.3877/cma.j.issn.2095-9605.2019.03.008

所属专题: 文献

综述

内镜下胃内球囊减肥术临床应用进展
于新颖1, 白日星2,(), 徐有青1, 闫文貌2   
  1. 1. 100050 北京,首都医科大学附属北京天坛医院消化内科
    2. 100050 北京,首都医科大学附属北京天坛医院普外科
  • 收稿日期:2019-06-16 出版日期:2019-08-30
  • 通信作者: 白日星

Clinical application progress of endoscopic gastric balloon surgery for weight loss

Xinying Yu1, Rixing Bai2(), Youqing Xu1   

  • Received:2019-06-16 Published:2019-08-30
  • Corresponding author: Rixing Bai
引用本文:

于新颖, 白日星, 徐有青, 闫文貌. 内镜下胃内球囊减肥术临床应用进展[J]. 中华肥胖与代谢病电子杂志, 2019, 05(03): 157-160.

Xinying Yu, Rixing Bai, Youqing Xu. Clinical application progress of endoscopic gastric balloon surgery for weight loss[J]. Chinese Journal of Obesity and Metabolic Diseases(Electronic Edition), 2019, 05(03): 157-160.

[1]
Collaborators GBDO, Afshin A, Forouzanfar MH, et al. Health Effects of Overweight and Obesity in 195 Countries over 25 Years[J]. The New England journal of medicine, 2017, 377(1): 13-27.
[2]
Arnold M, Pandeya N, Byrnes G, et al. Global burden of cancer attributable to high body-mass index in 2012: a population-based study[J]. The Lancet Oncology, 2015, 16(1): 36-46.
[3]
Polednak AP. Estimating the number of U.S. incident cancers attributable to obesity and the impact on temporal trends in incidence rates for obesity-related cancers[J]. Cancer detection and prevention, 2008, 32(3): 190-199.
[4]
Calle EE, Rodriguez C, Walker-Thurmond K, et al. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults[J]. The New England journal of medicine, 2003, 348(17): 1625-1638.
[5]
National Task Force on the P, Treatment of O. Overweight, obesity, and health risk[J]. Archives of internal medicine, 2000, 160(7): 898-904.
[6]
Mechanick JI, Youdim A, Jones DB, et al. Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient—2013 update: cosponsored by American Association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic & Bariatric Surgery[J]. Obesity, 2013, 21(Suppl 1): S1-27.
[7]
Obeid NR, Malick W, Concors SJ, et al. Long-term outcomes after Roux-en-Y gastric bypass: 10- to 13-year data[J]. Surgery for obesity and related diseases, 2016, 12(1): 11-20.
[8]
Buchwald H, Oien DM. Metabolic/bariatric surgery worldwide 2011[J]. Obesity surgery, 2013, 23(4): 427-436.
[9]
Ali MR, Moustarah F, Kim JJ, American Society for M, Bariatric Surgery Clinical Issues C. American Society for Metabolic and Bariatric Surgery position statement on intragastric balloon therapy endorsed by the Society of American Gastrointestinal and Endoscopic Surgeons[J]. Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery, 2016, 12(3): 462-467.
[10]
Force ABET, Committee AT, Abu Dayyeh BK, et al. ASGE Bariatric Endoscopy Task Force systematic review and meta-analysis assessing the ASGE PIVI thresholds for adopting endoscopic bariatric therapies[J]. Gastrointestinal endoscopy, 2015, 82(3): 425-438.
[11]
Imaz I, Martinez-Cervell C, Garcia-Alvarez EE, et al. Safety and effectiveness of the intragastric balloon for obesity. A meta-analysis[J]. Obesity surgery, 2008, 18(7): 841-846.
[12]
Dumonceau JM. Evidence-based review of the Bioenterics intragastric balloon for weight loss[J]. Obesity surgery, 2008, 18(12): 1611-1617.
[13]
Moura D, Oliveira J, De Moura EG, et al. Effectiveness of intragastric balloon for obesity: A systematic review and meta-analysis based on randomized control trials[J]. Surgery for obesity and related diseases, 2016,12(2): 420-429.
[14]
Nieben OG, Harboe H. Intragastric balloon as an artificial bezoar for treatment of obesity[J]. Lancet, 1982, 1 (8265): 198-199.
[15]
Ulicny KS, Jr., Goldberg SJ, Harper WJ, et al. Surgical complications of the Garren-Edwards Gastric Bubble[J]. Surgery, gynecology & obstetrics,1988, 166(6): 535-540.
[16]
Benjamin SB, Maher KA, Cattau EL, et al. Double-blind controlled trial of the Garren-Edwards gastric bubble: an adjunctive treatment for exogenous obesity[J]. Gastroenterology, 1988, 95(3): 581-588.
[17]
Gleysteen JJ. A history of intragastric balloons[J]. Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery, 2016, 12(2): 430-435.
[18]
Espinet-Coll E, Nebreda-Duran J, Gomez-Valero JA, et al. Current endoscopic techniques in the treatment of obesity[J]. Revista espanola de enfermedades digestivas: organo oficial de la Sociedad Espanola de Patologia Digestiva, 2012,104(2): 72-87.
[19]
Herve J, Wahlen CH, Schaeken A, et al. What becomes of patients one year after the intragastric balloon has been removed? [J] Obesity surgery, 2005, 15(6): 864-870.
[20]
Fuller NR, Pearson S, Lau NS, et al. An intragastric balloon in the treatment of obese individuals with metabolic syndrome: a randomized controlled study[J]. Obesity, 2013, 21(8): 1561-1570.
[21]
Lopez-Nava G, Rubio MA, Prados S, et al. BioEnterics(R) intragastric balloon (BIB(R)). Single ambulatory center Spanish experience with 714 consecutive patients treated with one or two consecutive balloons[J]. Obesity surgery, 2011, 21(1): 5-9.
[22]
Angrisani L, Lorenzo M, Borrelli V, et al. Is bariatric surgery necessary after intragastric balloon treatment?[J] Obesity surgery, 2006, 16(9): 1135-1137.
[23]
Ohta M, Kitano S, Kai S, et al. Initial Japanese experience with intragastric balloon placement[J]. Obesity surgery, 2009, 19(6): 791-795.
[24]
Genco A, Bruni T, Doldi SB, et al. BioEnterics Intragastric Balloon: The Italian Experience with 2,515 Patients[J]. Obesity surgery, 2005, 15(8): 1161-1164.
[25]
Lopasso FP, Sakai P, Gazi BM, et al. A pilot study to evaluate the safety, tolerance, and efficacy of a novel stationary antral balloon (SAB) for obesity[J]. Journal of clinical gastroenterology, 2008, 42(1): 48-53.
[26]
Ponce J, Woodman G, Swain J, et al. The REDUCE pivotal trial: a prospective, randomized controlled pivotal trial of a dual intragastric balloon for the treatment of obesity[J]. Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery, 2015, 11(4): 874-881.
[27]
Brooks J, Srivastava ED, Mathus-Vliegen EM. One-year adjustable intragastric balloons: results in 73 consecutive patients in the U.K.[J] Obesity surgery, 2014, 24(5): 813-819.
[28]
Genco A, Dellepiane D, Baglio G, et al. Adjustable intragastric balloon vs non-adjustable intragastric balloon: case-control study on complications, tolerance, and efficacy[J]. Obesity surgery, 2013, 23(7): 953-958.
[29]
Genco A, Ernesti I, Ienca R, et al. Safety and Efficacy of a New Swallowable Intragastric Balloon Not Needing Endoscopy: Early Italian Experience[J]. Obesity surgery, 2018, 28(2): 405-409.
[30]
Neto MG, Silva LB, Grecco E, et al. Brazilian Intragastric Balloon Consensus Statement (BIBC): practical guidelines based on experience of over 40,000 cases[J]. Surgery for obesity and related diseases, 2018, 14(2): 151-159.
[31]
Ozturk A, Akinci OF, Kurt M. Small intestinal obstruction due to self-deflated free intragastric balloon[J]. Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery, 2010,6(5): 569-571.
[1] 陈嘉婷, 杜美君, 石冰, 黄汉尧. 母体系统性疾病对新生儿唇腭裂发生的影响[J]. 中华口腔医学研究杂志(电子版), 2024, 18(04): 262-268.
[2] 孟令凯, 李大勇, 王宁, 王桂明, 张炳南, 李若彤, 潘立峰. 袖状胃切除术对肥胖伴2型糖尿病大鼠的作用及机制研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(06): 638-642.
[3] 李猛, 姜腊, 董磊, 吴情, 贾犇黎. 腹腔镜胃袖状切除术治疗肥胖合并2型糖尿病及脂肪胰的临床研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(05): 554-557.
[4] 杨波, 胡旭, 何金艳, 谢铭. 腹腔镜袖状胃切除术管胃固定研究现状[J]. 中华普外科手术学杂志(电子版), 2024, 18(04): 452-455.
[5] 兰华, 高丽莎, 申明, 张铭光. 内镜黏膜下剥离术后溃疡出血的研究进展[J]. 中华普外科手术学杂志(电子版), 2024, 18(04): 467-469.
[6] 宋红霞, 吴玩呈. 内镜下甲状腺手术切口入路发展的研究进展[J]. 中华普外科手术学杂志(电子版), 2024, 18(04): 470-472.
[7] 吉顺富, 汤晓燕, 徐进. 腹腔镜近端胃癌根治术中拓展胃后间隙在肥胖患者中的应用研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(04): 393-396.
[8] 邱小原, 林国乐, 牛备战, 陆君阳, 张冠南, 邱辉忠. TEM技术在中低位直肠癌个性化治疗中的应用[J]. 中华腔镜外科杂志(电子版), 2024, 17(04): 210-217.
[9] 梁艳娉, 列诗韵, 王艺穗, 吴晓瑛, 林颖. 基于内镜操作细节记录系统构建胃底静脉曲张内镜下组织胶注射术的标准化管理方案[J]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 705-709.
[10] 邵佳申, 张志武, 孟海, 杨雍, 费琦. 单侧双通道脊柱内镜技术治疗腰椎管狭窄症的临床疗效和学习曲线研究[J]. 中华老年骨科与康复电子杂志, 2024, 10(04): 202-208.
[11] 商倩, 罗静, 卓振山, 苗园园, 吴静, 廖振林. 通腑泻浊法联合生长抑素对内镜逆行胰胆管造影治疗的急性胆源性胰腺炎患者预后的影响[J]. 中华消化病与影像杂志(电子版), 2024, 14(05): 437-441.
[12] 梁艳娉, 陈燕柔, 梁运啸, 白飞虎, 吴斌, 王省. 华南地区门静脉高压食管胃静脉曲张出血内镜治疗现状调研分析[J]. 中华消化病与影像杂志(电子版), 2024, 14(05): 390-395.
[13] 刘燚隆, 党荣广, 艾蓉, 张凯. 肝硬化合并静脉曲张出血患者内镜治疗后再出血风险的模型建立与验证[J]. 中华消化病与影像杂志(电子版), 2024, 14(04): 336-342.
[14] 唐小久, 胡曼, 许必君, 肖亚. 肥胖合并胃食管反流病患者严重程度与其焦虑抑郁及营养状态的相关性研究[J]. 中华消化病与影像杂志(电子版), 2024, 14(04): 360-364.
[15] 王星, 陈园, 热孜万古丽·乌斯曼, 郭艳英. T2DM、Obesity、NASH、PCOS共同致病因素相关的分子机制[J]. 中华临床医师杂志(电子版), 2024, 18(05): 481-490.
阅读次数
全文


摘要